Literature DB >> 8242614

Identification of three regions on chromosome 17q in primary human breast carcinomas which are frequently deleted.

C S Cropp1, M H Champeme, R Lidereau, R Callahan.   

Abstract

We have examined the long arm of chromosome 17 in sporadic breast carcinomas for the loss of heterozygosity (LOH) at 18 polymorphic loci. At least three distinct regions could be identified by the frequency of LOH and confirmed by high density deletion maps of individual tumor DNAs. A proximal region affected by LOH is located in a 22-cM region defined by D17S73 and NME1 and thus is similar in location to the region thought to contain the BRCA1 gene associated with familial breast and breast/ovarian cancer. The central region affected by LOH is bordered by the D17S86 and D17S21 loci and is estimated to be 28 cM in size. The third region is bordered by the D17S20 and D17S77 loci which are 11 cM apart. These results define three independent regions of chromosome 17q which are likely to contain tumor suppressor genes relevant to the etiology of sporadic breast carcinoma.

Entities:  

Mesh:

Year:  1993        PMID: 8242614

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  Multiplex genotype analysis of invasive carcinoma and accompanying proliferative lesions microdissected from breast tissue.

Authors:  X Cui; H Feiner; Z Lin; H Li
Journal:  J Mol Diagn       Date:  2000-02       Impact factor: 5.568

2.  Analysis of BRCA1 involvement in breast cancer in Indian women.

Authors:  P H Pestonjamasp; I Mittra
Journal:  J Biosci       Date:  2000-03       Impact factor: 1.826

3.  A 100-kb physical and transcriptional map around the EDH17B2 gene: identification of three novel genes and a pseudogene of a human homologue of the rat PRL-1 tyrosine phosphatase.

Authors:  M Montagna; O Serova; B S Sylla; J Feunteun; G M Lenoir
Journal:  Hum Genet       Date:  1995-11       Impact factor: 4.132

Review 4.  Inherited predisposition to breast and ovarian cancer.

Authors:  S Rowell; B Newman; J Boyd; M C King
Journal:  Am J Hum Genet       Date:  1994-11       Impact factor: 11.025

5.  Identification of high-risk breast cancer patients from genetic changes of their tumors.

Authors:  M Watatani; H Inui; K Nagayama; Y Imanishi; K Nishimura; Y Hashimoto; E Yamauchi; T Hojo; Y Kotsuma; M Yamato; N Matsunami; M Yasutomi
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

6.  Allelic Losses from Chromosome 17 in Human Osteosarcomas.

Authors:  Marianna Sztán; Zsuzsa Pápai; Miklós Szendrôi; Marco van der Looij; Edith Oláh
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

7.  Microsatellite instability and loss of heterozygosity in mammary carcinoma and its probable precursors.

Authors:  E K Dillon; W B de Boer; J M Papadimitriou; G R Turbett
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  Allelic imbalance in the region of the BRCA1 gene in ductal carcinoma in situ of the breast.

Authors:  K E Munn; R A Walker; L Menasce; J M Varley
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

9.  Absence of methylation of CpG dinucleotides within the promoter of the breast cancer susceptibility gene BRCA2 in normal tissues and in breast and ovarian cancers.

Authors:  N Collins; R Wooster; M R Stratton
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer.

Authors:  M W Beckmann; F Picard; H X An; C R van Roeyen; S I Dominik; D S Mosny; H G Schnürch; H G Bender; D Niederacher
Journal:  Br J Cancer       Date:  1996-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.